Tenaya Therapeutics logo

Tenaya Therapeutics Share Price (NASDAQ: TNYA)

$1.12

-0.01

(-0.88%)

Last updated on

Check the interactive Tenaya Therapeutics Stock chart to analyse performance

Tenaya Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.09
    Today's High:$1.14

    Day's Volatility :4.41%

  • 52 Weeks Low:$0.36
    52 Weeks High:$4.01

    52 Weeks Volatility :91.02%

Tenaya Therapeutics Stock Returns

PeriodTenaya Therapeutics IncIndex (Russel 2000)
3 Months
145.65%
0.0%
6 Months
19.34%
0.0%
1 Year
-55.34%
0.0%
3 Years
-75.06%
-4.1%

Tenaya Therapeutics Inc Key Stats

Check Tenaya Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.13
Open
$1.13
Today's High
$1.135
Today's Low
$1.085
Market Capitalization
$184.2M
Today's Volume
$2.1M
52 Week High
$4.01
52 Week Low
$0.36
Revenue TTM
$0.0
EBITDA
$-94.0M
Earnings Per Share (EPS)
$-0.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-85.21%

Stock Returns calculator for Tenaya Therapeutics Stock including INR - Dollar returns

The Tenaya Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tenaya Therapeutics investment value today

Current value as on today

₹49,553

Returns

₹50,447

(-50.45%)

Returns from Tenaya Therapeutics Stock

₹55,731 (-55.73%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Tenaya Therapeutics Stock

40.63%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Tenaya Therapeutics Shares from India has grown by 40.63% over the past 30 days, indicating increased transactional activity.

19%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Tenaya Therapeutics Stock from India on INDmoney has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tenaya Therapeutics Inc

  • Name

    Holdings %

  • Column Group LLC

    5.77%

  • BlackRock Inc

    3.23%

  • Vanguard Group Inc

    2.92%

  • JPMorgan Chase & Co

    1.39%

  • AQR Capital Management LLC

    1.07%

  • Renaissance Technologies Corp

    0.95%

Analyst Recommendation on Tenaya Therapeutics Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Tenaya Therapeutics(by analysts ranked 0 to 5 stars)

Tenaya Therapeutics Share Price Target

What analysts predicted

Upside of 805.62%

Target:

$10.14

Current:

$1.12

Tenaya Therapeutics share price target is $10.14, a slight Upside of 805.62% compared to current price of $1.12 as per analysts' prediction.

Tenaya Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, TNYA stock has moved up by 67.2%
  • TNYA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 127.7%
  • TNYA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 190.3%

Tenaya Therapeutics Technicals Summary

Sell

Neutral

Buy

Tenaya Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Tenaya Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Tenaya Therapeutics Inc logo
68.51%
19.34%
-55.34%
-75.06%
-92.64%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Tenaya Therapeutics Inc

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company's lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in phase 2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in phase 1 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. The company develops its products through gene editing, cellular regeneration, gene silencing, and gene addition. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Organization
Tenaya Therapeutics
Employees
97
CEO
Mr. Faraz Ali M.B.A.
Industry
Miscellaneous

Key Management of Tenaya Therapeutics Inc

NameTitle
Mr. Faraz Ali M.B.A.
CEO, Interim Principal Financial Officer & Director
Dr. Deepak Srivastava M.D.
Scientific Founder, Chairman of Scientific Advisory Board & Director
Dr. Whittemore G. Tingley M.D., PH.D.
Chief Medical Officer
Dr. Eric N. Olson Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Dr. Bruce R. Conklin M.D.
Scientific Founder
Dr. Saptarsi Haldar M.D.
Scientific Founder
Dr. Sheng Ding Ph.D.
Scientific Founder
Dr. Benoit G. Bruneau Ph.D.
Scientific Founder
Mr. Tomohiro Higa M.B.A.
Senior Vice President of Finance & Interim Principal Accounting Officer
Dr. Kee-Hong Kim Ph.D.
Chief Technology Officer

Important FAQs about investing in TNYA Stock from India :

What is Tenaya Therapeutics share price today?

Tenaya Therapeutics share price today is $1.12 as on at the close of the market. Tenaya Therapeutics share today touched a day high of $1.14 and a low of $1.09.

What is the 52 week high and 52 week low for Tenaya Therapeutics share?

Tenaya Therapeutics share touched a 52 week high of $4.01 and a 52 week low of $0.36. Tenaya Therapeutics stock price today i.e. is closed at $1.12, lower by 72.07% versus the 52 week high.

How to invest in Tenaya Therapeutics Stock (TNYA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tenaya Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tenaya Therapeutics Shares that will get you 1.3393 shares as per Tenaya Therapeutics share price of $1.12 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tenaya Therapeutics Stock (TNYA) from India?

Indian investors can start investing in Tenaya Therapeutics (TNYA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Tenaya Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Tenaya Therapeutics share’s latest price of $1.12 as on August 30, 2025 at 1:29 am IST, you will get 8.9286 shares of Tenaya Therapeutics. Learn more about fractional shares .

What are the returns that Tenaya Therapeutics has given to Indian investors in the last 5 years?

Tenaya Therapeutics stock has given -92.64% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?